Alembic Pharmaceuticals is notifying shareholders who have not claimed dividends for seven consecutive years that their equity shares are at risk of being transferred to the Investor Education and Protection Fund (IEPF). To avoid the transfer of these shares, impacted investors must take necessary steps to claim their unpaid dividends by August 10, 2026. Failure to act by this deadline will result in the mandatory transfer of these assets to the government-administered fund.
Notice to Shareholders
Alembic Pharmaceuticals has identified shareholders who have not encashed their dividend warrants for the last seven consecutive years, starting from the 2018-2019 financial year. Under current government mandates, any shares associated with unclaimed dividends for this duration must be transferred to the Investor Education and Protection Fund.
How to Claim Your Dividends
If you believe you have unclaimed dividends, it is critical to verify your status immediately. Shareholders are requested to claim their unpaid amounts on or before August 10, 2026. Should the deadline pass without action, the shares will be transferred to the IEPF as required by law.
Support and Documentation
For any information or assistance regarding your unclaimed dividends, please contact the company’s Registrar and Share Transfer Agents (RTA), MUFG Intime India Private Limited. You may reach out to them via their dedicated helpdesk email or the office located in Vadodara.
Furthermore, shareholders holding physical shares are encouraged to ensure their KYC details—including PAN, address, mobile number, bank account information, and nomination—are up to date. Relevant forms (such as ISR-1, ISR-2, and SH-13) are available on the company’s investor relations website to ensure your records are compliant and to prevent future issues with dividend disbursements.
Source: BSE
